Atlas Trials

Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma

Clinical trial NCT01969435 · COMPLETED

Trial details

NCT number
NCT01969435
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hodgkin DiseaseLymphoma, Non-Hodgkin
Start date
2014-03-19
Primary completion
2015-09-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.